Services: Ingredientpharm offers solutions from international supply to taylor made solutions e.g. taste masking of costumer specific APIs.
category-services
ingredientpharm
ingredientpharmCPhI 2024: Welcome ingredientpharm in Milan/Italy
We are thrilled to announce ingredientpharm’s participation as an exhibitor at the prestigious CPhI worldwide exhibition, taking place on October 08-10, 2024, in Milan/Italy, booth 7B66. As a leading name in the pharmaceutical ingredients industry, ingredientpharm is dedicated to advancing the quality and efficacy of pharmaceutical excipients and API granulation. This year, we are excited to showcase our latest innovations and high-quality offerings: pharmaceutical pellets and granulated Ibuprofen DC100.
Pharmaceutical Pellets: Made for better formulations
At ingredientpharm, we understand the critical importance of precision and consistency in pharmaceutical manufacturing. Our pharmaceutical pellets are meticulously engineered to meet the highest standards of quality, uniformity and applicability to state-of-the-art formulations. These pellets offer superior opportunities for modified release profiles, enhancing the effectiveness of medications and ensuring patient compliance. Our advanced pelletization technologies guarantees that every batch delivers consistent quality, performance, providing pharmaceutical manufacturers with the reliability they need to produce safe and effective medicines. You have the choice for inert MCC pellets (CELLETS®) or functional starter beads (TAP®).
Granulated Ibuprofen DC100: A revolution in pain management
Introducing our groundbreaking product, granulated Ibuprofen DC100, a direct compression grade of Ibuprofen designed to streamline the tablet manufacturing process. This innovative granulation eliminates the need for complex processing steps, significantly reducing production time and costs. Ibuprofen DC100 is made of 100% API and comes without any need of further excipients. Ibuprofen DC100 ensures excellent flowability, compressibility, and dissolution properties, making it an ideal choice for manufacturers seeking to optimize their formulations. With this product, ingredientpharm is setting new standards in the production of non-steroidal anti-inflammatory drugs (NSAIDs), providing a reliable solution for effective pain management.
Visit Us at CPhI 2024
We invite you to visit our booth at CPhI 2024 to learn more about our cutting-edge pharmaceutical pellets and granulated Ibuprofen DC100. Our experts will be on hand to discuss how these products can enhance your formulation, improve efficiency, and benefit patients. Join us in exploring the future of pharmaceutical ingredients and discover why ingredientpharm is a trusted partner in the industry.
We look forward to seeing you at CPhI 2024 in Italy!
ingredientpharm
GlattOnline seminar recording: Functional Tartaric Acid Pellets in Modern Formulation Challenges
Apr 05, 2022. Register for the online seminar recordings: “Functional Tartaric Acid Pellets in Modern Formulation Challenges”.
Speakers: Philippe Tschopp, Raja Subburayalu, with kind session chair by Marco Resciniti.
Sponsoring companies: Glatt Group, ingredientpharm, PHARMATRANS SANAQ AG, HARKE GROUP.
Target group: for Manager working in Pharmaceutical Technology and Formulation Sciences.
Register here: Webinar-Registrierung – Zoom
Abstract: Functional Tartaric Acid Pellets in Modern Formulation Challenges
Multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption. Present generic formulations focus on these so-called BSC Class IV drugs. The Role of Reverse Engineering is thereby an efficient key tool in the development of generic formulations. A Case study presents latest state-of-the-art achievements.
Expert presenters
The live webcast will bring interesting case provided by Pharmatrans SANAQ® and technically discussed and presented by Philippe Tschopp, Business Development at Glatt Pharmaceutical Services in Germany and Dr. Raja Subburayalu, consultant in Manufacturing Science and Technology Transfer for Zydus Cadila Healthcare Limited, based in Ahmedabad, Gujarat, India.
Reverse Engineering
Dr Subburayalu will explore how present generic formulations focus on so-called BSC Class IV drugs in which multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption.
They will highlight how Reverse Engineering using TAP® can form an efficient key tool in the development of generic formulations. The webinar will feature a case study illustrating latest state-of-the-art achievements.
Register here for the online seminar recording
ingredientpharmPBP World Meeting, 2022
ingredientpharm will showcase its current portfolio of pelletized excipients and APIs at the 13th PBP World Meeting. The World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology takes place from 28 to 31 March 2022 in Rotterdam, The Netherlands. In collaboration with Glatt, the joint booth will also provide information on process technologies and offer personalized guidance for CDMO services.
Visit us on booth no. 12.
See: event information
This is on how the organizer sees PBP World Meeting
According to the organizers, the PBP World Meeting is gaining influence among pharmaceutical scientists. Nearly 1,000 abstracts were submitted, and over 1,300 participants attended. It has become a major event that attracts researchers from around the world.
The World Meetings take place every two years, usually in March or April of even-numbered years.
The conference covers a wide range of topics in Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology. It includes engineering aspects of manufacturing processes and the variety of commercially available excipients for drug products and medical devices. Basic sciences, such as physico-chemical principles, are also addressed. Attendees learn about advanced characterization techniques for dosage forms, both in vitro and in vivo. The meeting also highlights challenges in product development, manufacturing, and quality control.
GlattGlatt – an exceptional partner for integrated process solutions
GLATT is your exceptional partner for integrated process solutions for developing, processing and manufacturing powder solids. Develop powerful technologies, roll out innovative ideas, share our cumulative expertise worldwide – that is our mission. With integral solutions to make your business a success. As a pioneer in fluidized bed technology, we are now the exceptional partner to companies in the pharmaceutical, food, animal feed and fine chemicals industries. Glatt offers a unique portfolio of innovative products and extensive services to support your company across the entire process chain, including process development for new products and formulations, process technology, planning, right up to construction of the plant itself to manufacture your product.Benefit from quality, turn-key solutions from one source!
See: Glatt information
